ES2152860B1 - Forma cristalina de la nefazodona y procedimiento para su preparacion. - Google Patents

Forma cristalina de la nefazodona y procedimiento para su preparacion.

Info

Publication number
ES2152860B1
ES2152860B1 ES009802223A ES9802223A ES2152860B1 ES 2152860 B1 ES2152860 B1 ES 2152860B1 ES 009802223 A ES009802223 A ES 009802223A ES 9802223 A ES9802223 A ES 9802223A ES 2152860 B1 ES2152860 B1 ES 2152860B1
Authority
ES
Spain
Prior art keywords
nefazodone
procedure
preparation
dihydrate
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009802223A
Other languages
English (en)
Other versions
ES2152860A1 (es
Inventor
Surroca Juan J Artus
Jane Llorenc Rafecas
Bonet Montserrat Jane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Finaf 92 SA
Original Assignee
Finaf 92 SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finaf 92 SA filed Critical Finaf 92 SA
Priority to ES009802223A priority Critical patent/ES2152860B1/es
Priority to US09/418,760 priority patent/US6448404B1/en
Priority to EP99500188A priority patent/EP1000944A1/en
Priority to IL13252499A priority patent/IL132524A/en
Priority to CA002287105A priority patent/CA2287105A1/en
Publication of ES2152860A1 publication Critical patent/ES2152860A1/es
Application granted granted Critical
Publication of ES2152860B1 publication Critical patent/ES2152860B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Forma cristalina de la nefazodona y procedimiento para su preparación; la forma cristalina o clorhidrato de nefazodona dihidrato cristalino, es de nombre químico 2-{3-[4-(3- clorofenil)-1-piperazinil]propil}-5-etil-2,4-dihidro-4-(2- fenoxietil)-3H-1,2,4-triazol-3-ona clorhidrato dihidrato y de fórmula. **FORMULA** El procedimiento comprende la preparación del clorhidrato de nefazodona dihidrato cristalino cristalizando el clorhidrato de nefazodona dihidrato de una mezcla de solvente orgánico/agua que comprende al menos 0,2 partes en volumen de un solvente orgánico por cada parte en volumen de agua.
ES009802223A 1998-10-23 1998-10-23 Forma cristalina de la nefazodona y procedimiento para su preparacion. Expired - Fee Related ES2152860B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009802223A ES2152860B1 (es) 1998-10-23 1998-10-23 Forma cristalina de la nefazodona y procedimiento para su preparacion.
US09/418,760 US6448404B1 (en) 1998-10-23 1999-10-15 Crystalline form of nefazodone and process for the preparation thereof
EP99500188A EP1000944A1 (en) 1998-10-23 1999-10-18 Crystalline nefazodone hydrochloride dihydrate and process for the preparation thereof
IL13252499A IL132524A (en) 1998-10-23 1999-10-21 Crystalline state of napazodone hydrochloride dehydrate and process for its production
CA002287105A CA2287105A1 (en) 1998-10-23 1999-10-22 Crystalline form of nefazodone and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802223A ES2152860B1 (es) 1998-10-23 1998-10-23 Forma cristalina de la nefazodona y procedimiento para su preparacion.

Publications (2)

Publication Number Publication Date
ES2152860A1 ES2152860A1 (es) 2001-02-01
ES2152860B1 true ES2152860B1 (es) 2001-08-16

Family

ID=8305559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009802223A Expired - Fee Related ES2152860B1 (es) 1998-10-23 1998-10-23 Forma cristalina de la nefazodona y procedimiento para su preparacion.

Country Status (5)

Country Link
US (1) US6448404B1 (es)
EP (1) EP1000944A1 (es)
CA (1) CA2287105A1 (es)
ES (1) ES2152860B1 (es)
IL (1) IL132524A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356450C (en) 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
DE102004021494B4 (de) * 2004-04-30 2006-04-06 Man Roland Druckmaschinen Ag Vorrichtung zum Auf- und Abziehen einer Hülse
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
DE69729211T2 (de) * 1996-03-25 2005-05-04 Eli Lilly And Co., Indianapolis Tetrahydro-beta carbolinverbindungen

Also Published As

Publication number Publication date
CA2287105A1 (en) 2000-04-23
IL132524A (en) 2001-11-25
EP1000944A1 (en) 2000-05-17
ES2152860A1 (es) 2001-02-01
IL132524A0 (en) 2001-03-19
US6448404B1 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
Melchiorre et al. Molecular properties of the adrenergic. alpha. receptor. 2. Optimum covalent inhibition by two different prototypes of polyamine disulfides
UY26872A1 (es) Derivados de la 4- fenil piridina
RU98121016A (ru) Способ получения магниевой соли замещенного сульфинил-гетероцикла
BRPI0614805A2 (pt) poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
CA2149918A1 (en) Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
JP2005530811A5 (es)
KR850002270A (ko) 항우울증 작용을 가진 1,2,4-트리아졸론 화합물의 제조 방법
PT97700B (pt) Processo de preparacao de agentes terapeuticos anti-diabeticos
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
ES2152860B1 (es) Forma cristalina de la nefazodona y procedimiento para su preparacion.
KR860001078A (ko) 2-페닐알킬-3-아미노알킬-4(3h)-퀴나졸리논 화합물의 제조방법
BR0109508A (pt) Forma ii, cristalina, de cabergolina
RU2001109228A (ru) Ненасыщенные производные гидроксимовой кислоты в качестве ингибиторов NAD+-ADP-рибозилтрансферазы
RU2003122785A (ru) 9a-n-[n`-(фенилсульфонил)карбамоил)-производные 9-дезоксо-9-дигидро-9a-аза-9a-гомоэритромицина a и 5-o-дезозаминил-9-дезоксо-9-дигидро-9a-аза-9a-гомоэритронолида a
EA200101180A1 (ru) Производные тио-оксиндола
BR0008566A (pt) Processo para cristalização de n-(4-trifluormetilfenil)-5-metil-isoxazol-4-carboxamida
Aldujaili et al. SYNTHESIS AND CHARACTERIZATION OF NEW β-LACTAM DERIVATVE FROM SULFADIAZINE DRUG BY MANY STEPS: SYNTHESIS AND CHARACTERIZATION OF NEW β-LACTAM DERIVATVE FROM SULFADIAZINE DRUG BY MANY STEPS
PE17099A1 (es) Sales dimesilato de los ligandos del neuropeptido y
CO5070688A1 (es) Procedimiento para la cristalizacion de un derivado tetrahidropiridina, a las nuevas formas cristalinas asi obtenidas y a las composiciones farmaceuticas que contienen
SU614093A1 (ru) Многократнозамещенные диарил- -(трет.амино)пропанолы, про вл ющие диуретическое и салуретическое действие
KR880002826A (ko) 치환된 하이드록시프로필아민 유도체
TH58087B (th) กรรมวิธีการเตรียมออกซาโซลิติโนน
TH30461A (th) กรรมวิธีสำหรับการเตรียมเกลือแมกนีเชียมของซัลพินิล เฮทเทอโร-เฮทเทอโรไซเคิลที่ถูกแทนที่

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010201

Kind code of ref document: A1

Effective date: 20010201

FD2A Announcement of lapse in spain

Effective date: 20180807